These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 30850045)

  • 1. What's New in Genetic Skin Diseases.
    Hill CR; Theos A
    Dermatol Clin; 2019 Apr; 37(2):229-239. PubMed ID: 30850045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Diagnosis of Mosaic Overgrowth Syndromes Using a Custom-Designed Next-Generation Sequencing Panel.
    Chang F; Liu L; Fang E; Zhang G; Chen T; Cao K; Li Y; Li MM
    J Mol Diagn; 2017 Jul; 19(4):613-624. PubMed ID: 28502725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overgrowth Syndromes Caused by Somatic Variants in the Phosphatidylinositol 3-Kinase/AKT/Mammalian Target of Rapamycin Pathway.
    Akgumus G; Chang F; Li MM
    J Mol Diagn; 2017 Jul; 19(4):487-497. PubMed ID: 28502730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular diagnosis of somatic overgrowth conditions: A single-center experience.
    Lalonde E; Ebrahimzadeh J; Rafferty K; Richards-Yutz J; Grant R; Toorens E; Marie Rosado J; Schindewolf E; Ganguly T; Kalish JM; Deardorff MA; Ganguly A
    Mol Genet Genomic Med; 2019 Mar; 7(3):e536. PubMed ID: 30761771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)-related overgrowth spectrum: A brief report.
    Denorme P; Morren MA; Hollants S; Spaepen M; Suaer K; Zutterman N; Labarque V; Legius E; Brems H
    Pediatr Dermatol; 2018 May; 35(3):e186-e188. PubMed ID: 29493003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroadipose hyperplasia versus Proteus syndrome: segmental overgrowth with a mosaic mutation in the PIK3CA gene.
    Youssefian L; Vahidnezhad H; Baghdadi T; Ghaznavi A; Li Q; Tabrizi M; Uitto J
    J Invest Dermatol; 2015 May; 135(5):1450-1453. PubMed ID: 25602158
    [No Abstract]   [Full Text] [Related]  

  • 7. Overgrowth syndromes and new therapies.
    Eng W; Hammill AM; Adams DM
    Semin Pediatr Surg; 2020 Oct; 29(5):150974. PubMed ID: 33069285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Klippel-Trenaunay syndrome belongs to the PIK3CA-related overgrowth spectrum (PROS).
    Vahidnezhad H; Youssefian L; Uitto J
    Exp Dermatol; 2016 Jan; 25(1):17-9. PubMed ID: 26268729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of a uterine broad ligament leiomyoma in a patient with CLOVES syndrome.
    Karpathiou G; Chauleur C; Picot T; Peoc'h M
    Pathol Res Pract; 2020 Dec; 216(12):153285. PubMed ID: 33190013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of congenital lipomatous overgrowth, vascular malformations, epidermal nevi, spinal/skeletal anomalies and/or scoliosis syndrome with lipoatrophy as an important clinical manifestation.
    Schreiber A; Grenier PO; Auger I
    Pediatr Dermatol; 2017 Nov; 34(6):735-736. PubMed ID: 28833506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the study of somatic mosaicism and diseases other than cancer.
    Erickson RP
    Curr Opin Genet Dev; 2014 Jun; 26():73-8. PubMed ID: 25050467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overgrowth syndromes with complex vascular anomalies.
    Uller W; Fishman SJ; Alomari AI
    Semin Pediatr Surg; 2014 Aug; 23(4):208-15. PubMed ID: 25241100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic frameshift mutation in PIK3CA causes CLOVES syndrome by provoking PI3K/AKT/mTOR pathway.
    Yan W; Zhang B; Wang H; Mo R; Jiang X; Qin W; Ma L; Lin Z
    Hereditas; 2021 Jun; 158(1):18. PubMed ID: 34074347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Genetic Aspects of the Segmental Overgrowth Spectrum Due to Somatic Mutations in PIK3CA.
    Kang HC; Baek ST; Song S; Gleeson JG
    J Pediatr; 2015 Nov; 167(5):957-62. PubMed ID: 26340871
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum.
    Keppler-Noreuil KM; Sapp JC; Lindhurst MJ; Parker VE; Blumhorst C; Darling T; Tosi LL; Huson SM; Whitehouse RW; Jakkula E; Grant I; Balasubramanian M; Chandler KE; Fraser JL; Gucev Z; Crow YJ; Brennan LM; Clark R; Sellars EA; Pena LD; Krishnamurty V; Shuen A; Braverman N; Cunningham ML; Sutton VR; Tasic V; Graham JM; Geer J; Henderson A; Semple RK; Biesecker LG
    Am J Med Genet A; 2014 Jul; 164A(7):1713-33. PubMed ID: 24782230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic heterogeneity in PIK3CA-related overgrowth spectrum.
    Vahidnezhad H; Youssefian L; Baghdadi T; Sotoudeh S; Tavassoli A; Zeinali S; Afsharaalam S; Uitto J
    Br J Dermatol; 2016 Oct; 175(4):810-4. PubMed ID: 27037860
    [No Abstract]   [Full Text] [Related]  

  • 17. Mosaic Disorders of the PI3K/PTEN/AKT/TSC/mTORC1 Signaling Pathway.
    Nathan N; Keppler-Noreuil KM; Biesecker LG; Moss J; Darling TN
    Dermatol Clin; 2017 Jan; 35(1):51-60. PubMed ID: 27890237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Segmental overgrowth syndrome due to an activating PIK3CA mutation identified in affected muscle tissue by exome sequencing.
    Rasmussen M; Sunde L; Weigert KP; Bogaard PW; Lildballe DL
    Am J Med Genet A; 2014 May; 164A(5):1318-21. PubMed ID: 24665065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CLOVES syndrome.
    Bloom J; Upton J
    J Hand Surg Am; 2013 Dec; 38(12):2508-12. PubMed ID: 24161472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloves syndrome: a case report and perinatal diagnostic findings.
    Puvabanditsin S; Memon N; Chekmareva M; Di Stefano V; Mehta R
    Genet Couns; 2014; 25(3):265-70. PubMed ID: 25365848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.